Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H34N4O2S |
InChIKeySAVFOJHPVRSLGC-UHFFFAOYSA-N |
CAS Registry902940-64-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 29 Apr 2021 |